← FDA DRUG APPROVALS

FDA ANDA · ANDA210830

ELURYNG

etonogestrel and ethinyl estradiol

Sponsor: AMNEAL

APPLICATION
ANDA210830
TYPE
ANDA
ORIGINAL APPROVAL
2019-12-11
LATEST ACTION
2025-01-08
ROUTE
VAGINAL
DOSAGE FORM
RING
MARKETING STATUS
Prescription

Products

ELURYNGPrescription
ETHINYL ESTRADIOL 0.015MG/24HR, ETONOGESTREL 0.12MG/24HR · RING · VAGINAL

Approval history

2025-01-08Labeling · Supplement 20 · standardAP
2023-09-19Labeling · Supplement 12 · standardAP
2019-12-11UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →